Skip to content
Finance — Tech's Latest Innovations — Geek Gadgetry's Cloud Computing Hub — Unveil the Latest Gadgets

Rezon Bio Launches as Competitive CDMO in Poland

Rezon Bio's mirrored facilities and proven track record in biosimilars make it an attractive partner for the biologics industry. Its cooperation with Polpharma Biologics further strengthens its position.

,   and  Administrator
2 min read
This image is clicked in a room, where it looks like Store. There are so many bottles in this image...
This image is clicked in a room, where it looks like Store. There are so many bottles in this image and cans. There is a Banner in the middle which is indicating Supra brand. Bottom right corner there is a logo LM.

Rezon Bio Launches as Competitive CDMO in Poland

Rezon Bio, a new Contract Development and Manufacturing Organization (CDMO) in Poland, is set to make waves in the global industry. The company combines European location advantages with Poland's strong biopharma talent and cost structure to deliver competitive economics while maintaining high-quality standards.

Rezon Bio operates two state-of-the-art facilities in Gdańsk and Warsaw-Duchnice, offering an end-to-end path from cell line development through GMP manufacturing and commercial supply. Both facilities have mirrored capabilities, allowing seamless technology transfer and flexible scale-up, with infrastructure based on single-use systems for faster product turnover and accelerated delivery.

Dr. Paweł Swietochowski, founder and CEO of Rezon Bio, leads the company's mission to be the cost-efficient partner of choice for the global biologics industry. Rezon Bio operates under global entry compliance frameworks to meet the highest regulatory standards, with both facilities certified by the EMA, and the Gdańsk facility also approved by the US FDA.

Rezon Bio has a proven track record in biosimilars, with two products launched worldwide through partners. The company enters the market as a new brand but builds on a proven legacy of advancing biologics from gene to global commercialisation. It will make its first industry appearance at several key events, including the Festival of Biologics, the European Biomanufacturing Summit, CPHI Frankfurt, and BIO-Europe in Vienna.

In a strategic move, Polpharma Biologics in Switzerland will cooperate with Rezon Bio on market terms, further strengthening Rezon Bio's position in the global industry.

Rezon Bio's competitive economics, mirrored facilities, and proven track record make it an attractive partner for the global biologics industry. With its upcoming industry appearances and cooperation with Polpharma Biologics, Rezon Bio is poised to make a significant impact in the global biologics market.

Read also:

Related

Latest